Updates in Molluscum Contagiosum Management Digital Edition

Selected Abstracts from Maui Derm 2023 for Dermatologists Digital Edition

Natural Hair Supplements: Trends and Myths Untangled Digital Edition

2022 Conference Highlights: Acne

NP+PA PERSPECTIVES IN DERMATOLOGY

2022 Conference Highlights: Acne

NP+PA Perspectives in Dermatology: March 2023

Special Bonus Issue—Dermatology NP & PA Workforce Survey: Practice Characteristics and Compensation

ALL DIGITAL EDITIONS →

Tag: Pharmacokinetics

Sarecycline Treatment for Acne Vulgaris: Rationale for Weight-based Dosing and Limited Impact of Food Intake on Clinical Efficacy

September 1, 2022

Reproduced with permission from Dermatologic Therapy. 2022;35:e15275. by Ayman Grada, James Q. Del Rosso, Emmy Graber, Christopher G. Bunick, Linda Stein Gold, Angela Y. Moore, Hilary Baldwin, Zaidal Obagi, Giovanni

Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions

March 1, 2021

J Clin Aesthet Dermatol. 2021;14(3):E53–E57. by Terry M. Jones, MD, and Iain Stuart, PhD Dr. Jones is with J&S Studies Inc., in College Station, Texas. Dr. Stuart is with VYNE

Bioavailability, Pharmacokinetics, and Transepidermal Water Loss of Short-Contact Tazarotene Lotion 0.1% Versus Tazarotene (Tazorac®) Cream 0.1%

September 1, 2019

by Srinivas Sidgiddi, MD; Kent Allenby, MD; Franklin Okumu, PhD; and Anirudh Gautam, MPharm Drs. Sidgiddi, Allenby, and Okumu are with Promius Pharma in Princeton, New Jersey. Mr. Gautam is